Table 3 Baseline demographic and clinical characteristics of patients who underwent abdominal aortic replacement surgery and were extubated on the day of surgery in the operating room (Group A1) or in the ICU (Group A2)
Group A1 (n = 34) | Group A2 (n = 61) | Pvalue | |
|---|---|---|---|
Age (years) | 69 ± 8 | 69 ± 10 | 0.686 |
Height (cm) | 164.4 ± 6.1 | 164.4 ± 8.6 | 0.993 |
Weight (kg) | 61.1 ± 8.6 | 59.8 ± 8.9 | 0.510 |
Female | 0 (0.0%) | 11 (18.0%) | 0.007 |
Medical history | |||
Hypertension | 21 (61.8%) | 42 (68.9%) | 0.484 |
Diabetes mellitus | 5 (14.7%) | 15 (24.6%) | 0.257 |
Hyperlipidemia | 7 (20.6%) | 14 (23.0%) | 0.790 |
Chronic obstructive pulmonary disease | 4 (11.8%) | 3 (4.9%) | 0.245 |
Interstitial pneumonia | 0 (0.0%) | 1 (1.6%) | 1.000 |
Asthma | 1 (2.9%) | 3 (4.9%) | 1.000 |
Angina pectoris | 5 (14.7%) | 4 (6.6%) | 0.274 |
Previous cardiac surgery | 3 (8.8%) | 11(18.0%) | 0.366 |
Coronary intervention | 8 (23.5%) | 7 (11.5%) | 0.123 |
Smoking | 15 (44.1%) | 26 (42.6%) | 0.888 |
Arrhythmia | 5 (14.7%) | 1 (1.6%) | 0.021 |
Cardiac disease | 1 (2.9%) | 1 (1.6%) | 1.000 |
Hemodialysis | 0 (0.0%) | 2 (3.3%) | 0.536 |
Medication | |||
Calcium channel blocking agent | 18 (52.9%) | 27 (44.3%) | 0.417 |
β receptor blocker | 10 (29.4%) | 7(11.5%) | 0.029 |
ARB/ACEI | 13 (38.2%) | 30 (49.2%) | 0.304 |
Statin | 7 (20.6%) | 13 (21.3%) | 0.934 |